Arcline Investment Management Acquires Polypeptide Therapeutic Solutions

Arcline Investment Management (“Arcline”), a growth-oriented private equity firm with $4.3 billion of cumulative capital commitments, today announced the acquisition of Polypeptide Therapeutic Solutions, S.L. (“PTS” or “the Company”) from Columbus Venture Partners.   PTS is a leading GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications, including mRNA, DNA, cell therapies,…

Proyecto PTS 2018

Polypeptide Therapeutic Solutions, S.L. ha desarrollado con éxito durante 2018 un proyecto denominado “DESARROLLO Y VALIDACIÓN DE METODOLOGÍAS ANALÍTICAS PARA ANÁLISIS DE HIDROGELES COMO MATRIZ DE MATERIALES POLIPEPTÍDICOS” para el que ha contado con el apoyo de la Agencia Valenciana de la Innovación, a través de su programa de apoyo “Promoción del talento”, en su…

Novel Nanocarriers

A novel strategy developed by Aroa Duro-Castaño, Vicent J. Nebot, María J. Vicent and co-workers to produce nanosized drug carriers may improve the anticancer drug activity of polymer therapeutics and patient treatment http://onlinelibrary.wiley.com/doi/10.1002/adma.201770280/abstract